Medicine for reducing serum uric acid, preparation method thereof and purpose thereof

Abstract

The invention which belongs to the field of traditional Chinese medicines discloses a medicine for reducing serum uric acid, a preparation method thereof and a purpose thereof. The medicine is prepared from the following medicinal materials, by weight, 5-15 parts of edible tulip bulb, 10-60 parts of Smilax glabra, 6-30 parts of parasitic loranthus, 9-45 parts of Radix Astragali, 10-30 parts of Savia miltiorrhiza, 10-60 parts of coix seed, and 9-20 parts of Gentiana macrophylla. The medicinal materials are subjected to technologies of decoction, concentration, impurity removal, drying and the like to obtain effective parts for reducing serum uric acid, and the effective parts can be prepared into different clinically acceptable dosage forms with routine methods. The purpose comprises applications in preparing medicines for reducing serum uric acid, blood fat and protecting livers and kidneys, and applications of medicines for treating hyperuricacidemia or concurrent hyperuricacidemia. The medicine of the present invention which has effects of reducing serum uric acid, blood fat and protecting livers and kidneys can be used for treating hyperuricacidemia or concurrent hyperuricacidemia.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and in particular relates to a medicine for reducing blood uric acid, a preparation method and application thereof. Background technique [0002] Hyperuricemia is a group of diseases caused by purine metabolism disorder or decreased uric acid excretion. Clinically asymptomatic hyperuricemia is very common. If hyperuricemia cannot be controlled in time, urates will be deposited in the kidneys. Or joints and other tissues, causing pathological changes, is the inducing factor of gout, diabetes, coronary heart disease and other peripheral vascular diseases, the potential risk is very high, seriously affects the quality of life of patients, increases the medical burden, most of the clinical treatment of hyperuricemia All the chemical synthetic drugs have certain toxicity and side effects, and the abnormality reappears after stopping the drug. At the same time, the incidence of hyperuricemi...

AI Technical Summary

Problems solved by technology

[0002] Hyperuricemia is a group of diseases caused by purine metabolism disorder or decreased excretion of uric acid. Clinically asymptomatic hyperuricemia is very common. If hyperuricemia cannot be controlled in time, urates will be deposited in the kidneys. Or joints and other tissues, causing pathological changes, is the inducing factor of gout, diabetes, coronary heart disease and other peripheral vascular diseases, the potential risk is very high, seriously affects the quality of life of patients, increases the medical burden, most of the clinical treatment of hyperuricemia All chemical synthetic drugs have certain toxicity and side effects, and the abnormality reappears after stopping the drug.

At the same time, the incidence of hyperuricemia and hyperlipidemia caused by a high-purine and high-fat diet also showed a significant upward trend. Although blood lipid regulating drugs have good curative effects, there are blood lipid recurrences after drug withdrawal, or varying degrees. Side effects, high price, etc.

Images